ALPHA TRIBE

Venus Remedies LimitedBoard Meeting, 29-01-2026: Outcome of Board Meeting

29-01-2026 | 06:01 pm

Venus Remedies' board approved Q3 & nine-month results. Consolidated Revenue from Operations hit ₹180.26 Cr, Net Profit ₹25.58 Cr. Subsidiary Venus Pharma GmbH faces negative net worth (₹0.94 Cr), but management expects recovery and stability by FY26 end.

No comments yet. Be the first to comment!

All announcements from Venus Remedies Limited